442 related articles for article (PubMed ID: 10469779)
1. For-profit versus not-for-profit dialysis care for children with end stage renal disease.
Furth SL; Hwang W; Neu AM; Fivush BA; Powe NR
Pediatrics; 1999 Sep; 104(3 Pt 1):519-24. PubMed ID: 10469779
[TBL] [Abstract][Full Text] [Related]
2. Does greater pediatric experience influence treatment choices in chronic disease management? Dialysis modality choice for children with end-stage renal disease.
Furth SL; Powe NR; Hwang W; Neu AM; Fivush BA
Arch Pediatr Adolesc Med; 1997 Jun; 151(6):545-50. PubMed ID: 9193235
[TBL] [Abstract][Full Text] [Related]
3. Association Between Dialysis Facility Ownership and Access to the Waiting List and Transplant in Pediatric Patients With End-stage Kidney Disease in the US.
Amaral S; McCulloch CE; Lin F; Grimes BA; Furth S; Warady B; Brunson C; Siyahian S; Ku E
JAMA; 2022 Aug; 328(5):451-459. PubMed ID: 35916847
[TBL] [Abstract][Full Text] [Related]
4. Racial differences in choice of dialysis modality for children with end-stage renal disease.
Furth SL; Powe NR; Hwang W; Neu AM; Fivush BA
Pediatrics; 1997 Apr; 99(4):E6. PubMed ID: 9099781
[TBL] [Abstract][Full Text] [Related]
5. Association Between Dialysis Facility Ownership and Access to Kidney Transplantation.
Gander JC; Zhang X; Ross K; Wilk AS; McPherson L; Browne T; Pastan SO; Walker E; Wang Z; Patzer RE
JAMA; 2019 Sep; 322(10):957-973. PubMed ID: 31503308
[TBL] [Abstract][Full Text] [Related]
6. Dialysis facility ownership and epoetin dosing in patients receiving hemodialysis.
Thamer M; Zhang Y; Kaufman J; Cotter D; Dong F; Hernán MA
JAMA; 2007 Apr; 297(15):1667-74. PubMed ID: 17440144
[TBL] [Abstract][Full Text] [Related]
7. Effect of the ownership of dialysis facilities on patients' survival and referral for transplantation.
Garg PP; Frick KD; Diener-West M; Powe NR
N Engl J Med; 1999 Nov; 341(22):1653-60. PubMed ID: 10572154
[TBL] [Abstract][Full Text] [Related]
8. The ownership of health facilities and clinical decisionmaking. The case of the ESRD industry.
Schlesinger M; Cleary PD; Blumenthal D
Med Care; 1989 Mar; 27(3):244-58. PubMed ID: 2648087
[TBL] [Abstract][Full Text] [Related]
9. The production of dialysis by for-profit versus not-for-profit freestanding renal dialysis facilities.
Griffiths RI; Powe NR; Gaskin DJ; Anderson GF; de Lissovoy GV; Whelton PK
Health Serv Res; 1994 Oct; 29(4):473-87. PubMed ID: 7928373
[TBL] [Abstract][Full Text] [Related]
10. Comparison of hospitalization rates among for-profit and nonprofit dialysis facilities.
Dalrymple LS; Johansen KL; Romano PS; Chertow GM; Mu Y; Ishida JH; Grimes B; Kaysen GA; Nguyen DV
Clin J Am Soc Nephrol; 2014 Jan; 9(1):73-81. PubMed ID: 24370770
[TBL] [Abstract][Full Text] [Related]
11. Dialysis Facility Profit Status and Early Steps in Kidney Transplantation in the Southeastern United States.
McPherson LJ; Walker ER; Lee YH; Gander JC; Wang Z; Reeves-Daniel AM; Browne T; Ellis MJ; Rossi AP; Pastan SO; Patzer RE;
Clin J Am Soc Nephrol; 2021 Jun; 16(6):926-936. PubMed ID: 34039566
[TBL] [Abstract][Full Text] [Related]
12. Association between Freestanding Dialysis Facility Size and Medicare Quality Incentive Program Performance Scores.
Ajmal F; Probst J; Brooks J; Hardin J; Qureshi Z
Am J Nephrol; 2019; 49(1):64-73. PubMed ID: 30557871
[TBL] [Abstract][Full Text] [Related]
13. Impact of facility size and profit status on intermediate outcomes in chronic dialysis patients.
Frankenfield DL; Sugarman JR; Presley RJ; Helgerson SD; Rocco MV
Am J Kidney Dis; 2000 Aug; 36(2):318-26. PubMed ID: 10922310
[TBL] [Abstract][Full Text] [Related]
14. Reexploring differences among for-profit and nonprofit dialysis providers.
Lee DK; Chertow GM; Zenios SA
Health Serv Res; 2010 Jun; 45(3):633-46. PubMed ID: 20403066
[TBL] [Abstract][Full Text] [Related]
15. Dialysis chains and placement on the waiting list for a cadaveric kidney transplant.
Zhang Y; Thamer M; Kshirsagar O; Cotter DJ; Schlesinger MJ
Transplantation; 2014 Sep; 98(5):543-51. PubMed ID: 24798304
[TBL] [Abstract][Full Text] [Related]
16. A national study of efficiency for dialysis centers: an examination of market competition and facility characteristics for production of multiple dialysis outputs.
Ozgen H; Ozcan YA
Health Serv Res; 2002 Jun; 37(3):711-32. PubMed ID: 12132602
[TBL] [Abstract][Full Text] [Related]
17. Access to recombinant erythropoietin by Medicare-entitled dialysis patients in the first year after FDA approval.
Powe NR; Griffiths RI; de Lissovoy G; Anderson GF; Watson AJ; Greer JW; Herbert RJ; Eggers PW; Milam RA; Whelton PK
JAMA; 1992 Sep; 268(11):1434-40. PubMed ID: 1512912
[TBL] [Abstract][Full Text] [Related]
18. The effect of dialysis chains on mortality among patients receiving hemodialysis.
Zhang Y; Cotter DJ; Thamer M
Health Serv Res; 2011 Jun; 46(3):747-67. PubMed ID: 21143480
[TBL] [Abstract][Full Text] [Related]
19. For-profit status and industry evolution in health care markets: evidence from the dialysis industry.
Wilson NE
Int J Health Econ Manag; 2016 Dec; 16(4):297-319. PubMed ID: 27878689
[TBL] [Abstract][Full Text] [Related]
20. Relation between pediatric experience and treatment recommendations for children and adolescents with kidney failure.
Furth SL; Hwang W; Yang C; Neu AM; Fivush BA; Powe NR
JAMA; 2001 Feb; 285(8):1027-33. PubMed ID: 11209173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
